AmerisourceBergen Reports Fiscal 2021 Second Quarter Results

AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 second quarter ended March 31, 2021, revenue increased 3.7 percent year-over-year to $49.2 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $2.10 for the March quarter of fiscal 2021, compared to $4.64 in the prior year quarter. Adjusted diluted EPS, which is a non-GAAP measure that excludes items described below, increased 5.4 percent to $2.53 in the fiscal second quarter.

AmerisourceBergen is updating its outlook for fiscal year 2021. The Company does not provide forward-looking guidance on a GAAP basis, as discussed below in Fiscal Year 2021 Expectations. Adjusted diluted EPS guidance has been raised from the previous expectation of $8.40 to $8.60 to a range of $8.45 to $8.60, reflecting growth of 7 percent to 9 percent versus the previous fiscal year.

"AmerisourceBergen continues to prove our vital role as a key pillar in the healthcare system. Our solid performance in the March quarter was fueled by our associates who continue to work diligently to provide innovative solutions for our partners to ultimately serve their patients," said Steven H. Collis, Chairman, President and Chief Executive Officer of AmerisourceBergen.

"Driven by our purpose of being united in our responsibility to create healthier futures, we are strengthening our portfolio of solutions for customers, expanding on our leadership in specialty, focusing on execution and leveraging our capabilities and expertise to support pharmaceutical innovation," Mr. Collis continued. "AmerisourceBergen is well-positioned to deliver long-term, sustainable growth, supported by our diverse and inclusive teams and our investments in our people and culture."

Second Quarter Fiscal Year 2021 Summary Results

		GAAP		Adjusted (Non-GAAP)
Revenue		$49.2B		$49.2B
Gross Profit		$1.5B		$1.5B
Operating Expenses		$909M		$806M
Operating Income		$624M		$707M
Interest Expense, Net		$35M		$35M
Effective Tax Rate		23.4%		21.9%
Net Income Attributable to ABC		$435M		$524M
Diluted Earnings Per Share		$2.10		$2.53
Diluted Shares Outstanding AmerisourceBergen Corporation :ABC ABC Rankings N/A Ranked by Market Cap N/A Ranked by Dividends ABC Latest News Oct 2, 2023 Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release Aug 30, 2023 AmerisourceBergen becomes Cencora, in alignment with the company’s growing global footprint and central role in pharmaceutical access and care Aug 15, 2023 AmerisourceBergen Elects Werner Baumann and Lauren Tyler to Its Board of Directors Aug 3, 2023 Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.85 Billion of Initial Proceeds Aug 3, 2023 AmerisourceBergen Announces Registered Public Offering of Common Shares and Common Share Repurchase ABC Stock Data Market Cap 36.15B Float 169.43M Insiders Ownership 16.68% Institutions Ownership 78.92% Short Percent 3.5% Explore About Rhea-AI Sitemap Legal Terms of Use Cookie Notice Privacy Policy Links RSS feed Patreon Discord Server Facebook Reddit © 2020-2024 StockTitan.net